The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists [PDF]
J Obes Metab Syndr, 2019 The only known, effective intervention for non-alcoholic fatty liver disease (NAFLD) is weight loss, and there is no approved pharmacotherapy. Recently, new hypoglycemic agents, such as sodium-glucose cotransporter 2 (SGLT2) inhibitors and glucagon-like ...
C. Jung, J. Mok
semanticscholar +2 more sources
Comparison of baseline characteristics and clinical course in Japanese patients with type 2 diabetes among whom different types of oral hypoglycemic agents were chosen by diabetes specialists as initial monotherapy (JDDM 42) [PDF]
Medicine, 2017 Little is known about the relationships between patient factors and the antihyperglycemic agents that have been prescribed as initial therapy by diabetes specialists for patients with type 2 diabetes.
Fujihara Kazuya +12 more
core +2 more sources
Design and synthesis of novel thiazolidine-2,4-diones as hypoglycemic agents
Journal of Saudi Chemical Society, 2012 Thiazolidinediones are well known for causing reduction in blood glucose levels. A number of thiazolidinediones have been approved for clinical use in diabetes.
Prasanna A. Datar, Sainath Babaji Aher
semanticscholar +4 more sources
Gestational diabetes mellitus management with oral hypoglycemic agents. [PDF]
Semin Perinatol, 2014 Oral hypoglycemic agents such as glyburide (second-generation sulfonylurea) and metformin (biguanide) are attractive alternatives to insulin due to lower cost, ease of administration, and better patient adherence.
Rachel Ryu, Karen E Hays, M. Hebert
semanticscholar +2 more sources
Cocos Nucifera Endocarp Extract Exhibits Anti-diabetic and Antilipidemic Activities in Diabetic Rat Model [PDF]
International Journal of Scientific Research in Dental and Medical Sciences, 2022 Background and aim: The fruits of Cocos nucifera have long been used in traditional medicine as anti-inflammatory, antimicrobial, antiparasitic, anticancer, and cardiotonic.
Farjana Akter +5 more
doaj +1 more source
Adulteration of hypoglycemic products: the silent threat [PDF]
Romanian Journal of Medical Practice, 2023 Background. The growing tendency toward the adulteration of hypoglycemic products in the market to increase the seller’s profits, the increased promotions of such products by unscrupulous promoters, and the higher rate of consumption by diabetic patients
Raniah I. Alnaser +2 more
doaj +1 more source
Blood glucose, antidiabetic drugs, and risk of stroke [PDF]
Precision and Future Medicine, 2021 Diabetes mellitus is a well-established risk factor for stroke. Among people without baseline diabetes or cardiovascular disease, a low fasting glucose level of < 70 mg/dL is associated with an increased risk of stroke.
Meng Lee, Bruce Ovbiagele
doaj +1 more source
THE EFFECTS OF DIET AND HYPOGLYCEMIC AGENTS ON FASTING BLOOD SUGAR AND GLYCOSYLATED HAEMOGLOBIN CONCENTRATIONS IN TYPE TWO DIABETIC PATIENTS IN MOSUL POPULATION [PDF]
The Medical Journal of Basrah University, 2007 The study was conducted on 210 patients of both sexes suffering from Type 2 Diabetes Mellitus to investigate the effected of diet or hypoglycemic agents therapy on fasting blood sugar (FBS) and glycosylated haemoglobin (HbA1c).
Wail Moneer Mohammed Sadiq +1 more
doaj +1 more source
Journal of Pharmaceutical Health Care and Sciences, 2020 Background Patients with diabetes are at higher risk of developing polypharmacy because of the high frequency of comorbidities. There have been several reports on the hypoglycemic risk of the combination of hypoglycemic agents and other medications. This
Tomoyuki Saito +3 more
doaj +1 more source
Definitions, 2020 The pharmacology of the two general groups of oral anti-diabetic agents, namely the sulfonylureas and biguanides, are briefly discussed here. The sulfonylureas have a common hypoglycemic core.
Harold Rifkin
semanticscholar +1 more source